10/18/2017
Sponsored content: Boston Globe + Pfizer = News? Really?
10/11/2017
More evidence that women should be wary of ‘ovarian reserve testing’ events
9/26/2017
A prostate ‘Pep Talk’ is the wrong way to get men thinking about cancer screening
9/5/2017
Facts about the new ALS drug Radicava that you’re unlikely to see in news stories
9/1/2017
A $475,000 cancer drug: Wall Street sees ‘bargain’; patients see ‘completely broken’ system
8/16/2017
Investors aren’t the only ones burned by misleading drug company news releases
8/14/2017
Why you should be wary of ‘ovarian reserve testing’ events at fertility clinics
7/20/2017
Journalists and consumers need to immunize themselves against hype about unproven vaccines
7/19/2017
Stem cell ads: Promise much, deliver little
5/16/2017
Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings
